Beta Bionics, Inc.
BBNX
$28.31
-$1.07-3.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 17.28% | 31.74% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 17.28% | 31.74% | |||
| Cost of Revenue | 13.03% | 23.85% | |||
| Gross Profit | 20.92% | 39.37% | |||
| SG&A Expenses | 1.98% | 17.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.75% | 18.82% | |||
| Operating Income | 14.24% | -6.60% | |||
| Income Before Tax | 15.77% | 41.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 15.77% | 41.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.77% | 41.13% | |||
| EBIT | 14.24% | -6.60% | |||
| EBITDA | 14.68% | -6.47% | |||
| EPS Basic | 16.26% | 58.33% | |||
| Normalized Basic EPS | 16.26% | 58.33% | |||
| EPS Diluted | 16.26% | 58.33% | |||
| Normalized Diluted EPS | 16.26% | 58.33% | |||
| Average Basic Shares Outstanding | 0.56% | 41.27% | |||
| Average Diluted Shares Outstanding | 0.56% | 41.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||